Evidence map›Paper›PMID 41509530›Full record

ArticleGynecologic oncology reports2026

Solitary mandibular recurrence of uterine endometrial carcinoma successfully treated with chemotherapy alone: A case report.

Takato Ishida, Shoji Maenohara, Hiroshi Yagi, Hideaki Yahata, Kiyoko Kato

Abstract readCase Reports
In one paragraph

Article in Gynecologic oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Takato IshidaDepartment of Obstetrics and Gynecology, Kyushu University Hospital, Japan.
Shoji MaenoharaDepartment of Obstetrics and Gynecology, Kyushu University Hospital, Japan.
Hiroshi YagiDepartment of Obstetrics and Gynecology, Kyushu University Hospital, Japan.
Hideaki YahataDepartment of Obstetrics and Gynecology, Kyushu University Hospital, Japan.
Kiyoko KatoDepartment of Obstetrics and Gynecology, Kyushu University Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Recurrence of endometrial carcinoma typically occurs in the pelvic region, with the lungs and lymph nodes being common sites for distant metastasis. However, recurrence involving the head and neck region is exceedingly rare. Case presentation: We report a case of solitary mandibular recurrence of endometrial carcinoma successfully treated with lenvatinib and pembrolizumab. A 56-year-old woman was diagnosed with stage II clear cell carcinoma of the uterus. She underwent total abdominal hysterectomy, bilateral adnexectomy, partial omentectomy, appendectomy, pelvic and Conclusion: Mandibular metastasis from endometrial carcinoma is extremely rare and may mimic primary jaw tumors. Treatment options include surgical resection, radiotherapy, and systemic therapy. A comprehensive evaluation of the primary tumor status, presence of other metastases, and the patient's functional condition is essential for determining the optimal therapeutic strategy.

Indexed as

ChemotherapyEndometrial carcinomaMandibular recurrencePembrolizumab

Identifiers

PMID41509530
PMCPMC12775876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.